FDA observed filthy 'clean rooms' at NECC facility associated with meningitis outbreak
FDA investigators issue a 483 form that details the filthy conditions at the NECC in Framingham, Mass., that has been implicated in the national meningitis outbreak.
Recent Videos
Related Content
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Podcast
Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
